Petefészekrák: vizsgálatok itt: Szerbia
1 trial · From ClinicalTrials.gov, checked 2026. november 18.. Ask the study team whether a trial fits you.
- 1. fázisBefejeződöttA Study of Azenosertib (ZN-c3) in Patients With Ovarian Cancer
- Where
- Belgrade
- Életkor
- 18 év and over
- People
- 172 worldwide
- Run by
- K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc
See details and how to joinNCT04516447 · EU 2025-524868-38-00